R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program

R38 斯坦福综合心血管/肺部住院医师研究培训计划

基本信息

  • 批准号:
    10565903
  • 负责人:
  • 金额:
    $ 32.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-02-10 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Stanford University School of Medicine is a site of unparalleled excellence in biomedical research and is a innovative leader in the fields of cardiovascular and pulmonary medicine. The Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program described in this proposal will provide research opportunities for talented individuals engaged in the residency stage of their medical training. The program will draw resident investigators from the Stanford residency programs in Internal Medicine, Pediatrics, Cardiothoracic Surgery, and Radiology, and place them in basic, translational, and clinical research laboratories affiliated with the Stanford Cardiovascular Institute (CVI) for a mentored research experience lasting 1-2 years. Upon completion of their clinical training, successful resident-investigators would be eligible for K38 funding to support continued research efforts. This program would also fill a particular need of the Cardiothoracic Surgery and Anesthesiology residency programs, which require their trainees to dedicate a period of their time to research and would provide new and valuable opportunities for residents in other specialties. Research mentors for the proposed StARR program would be members of the Stanford CVI, which offers a unique platform by which to train the next generation of basic and translational scientists. Major research programs within the CVI are organized into Cardiac, Vascular, and Pulmonary disease categories, incorporating the disciplines of Genomics, Proteomics and Bioinformatics; Cellular and Molecular Biology; Imaging; Bioengineering; and Population Science. CVI scientists share a common interest in the mechanisms behind cardiovascular and pulmonary medicine, and work together towards creating novel therapeutic, regenerative, and preventative approaches to cardiovascular and pulmonary diseases. Furthermore, the CVI already offers multifaceted educational and career development programs that would enhance the experience of StARR trainees and prepare them to launch successful careers as future clinician scientists with successful academic careers.
项目摘要 斯坦福大学医学院是生物医学研究领域无与伦比的卓越之地, 心血管和肺部医学领域的创新领导者。斯坦福大学综合 本提案中描述的心血管/肺科住院医师研究培训计划将提供 研究机会,为有才华的个人从事住院医师阶段的医疗培训。的 该计划将吸引来自斯坦福大学内科,儿科, 心胸外科和放射学,并将其放置在基础,转化和临床研究实验室 附属于斯坦福大学心血管研究所(CVI),获得持续1-2年的指导研究经验 年完成临床培训后,成功的住院研究者将有资格参加K38 资助继续研究工作。该计划还将满足心胸外科的特殊需求。 外科和麻醉学住院医师项目,要求受训者将一段时间 研究,并将提供新的和宝贵的机会,在其他专业的居民。研究 拟议中的StARR计划的导师将是斯坦福大学CVI的成员,该组织提供了一个独特的平台 培养下一代基础科学家和转化科学家。主要研究项目在 CVI分为心脏、血管和肺部疾病类别,合并了以下学科 基因组学、蛋白质组学和生物信息学;细胞和分子生物学;成像;生物工程;以及 人口科学CVI科学家对心血管疾病背后的机制有着共同的兴趣, 肺医学,并共同努力创造新的治疗,再生,和预防 心血管和肺部疾病的治疗方法。此外,CVI已经提供了多方面的 教育和职业发展计划,以提高StARR受训人员的经验, 准备他们推出成功的职业生涯作为未来的临床科学家与成功的学术生涯。

项目成果

期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Diminishing Basic Science Research Experience Among United States Cardiothoracic Surgery Trainees.
  • DOI:
    10.1016/j.jss.2022.06.020
  • 发表时间:
    2022-11
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Wang, Hanjay;Bajaj, Simar S.;Manjunatha, Keerthi;Yu, Maggie M.;Obafemi, Oluwatomisin O.;Williams, Kiah M.;Boyd, Jack H.
  • 通讯作者:
    Boyd, Jack H.
An automated line-clearing chest tube system after cardiac surgery.
心脏手术后自动清理胸管系统。
  • DOI:
    10.1016/j.xjon.2022.02.020
  • 发表时间:
    2022-06
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Obafemi, Oluwatomisin Olurotimi;Wang, Hanjay;Bajaj, Simar S;O'Donnell, Christian T;Elde, Stefan;Boyd, Jack H
  • 通讯作者:
    Boyd, Jack H
Biomechanics and clinical outcomes of various conduit configurations in valve sparing aortic root replacement.
  • DOI:
    10.21037/acs-2023-avs2-0068
  • 发表时间:
    2023-07-31
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Zhu, Yuanjia;Park, Matthew H.;Pandya, Pearly K.;Stark, Charles J.;Mullis, Danielle M.;Walsh, Sabrina K.;Kim, Joo Young;Wu, Catherine A.;Baccouche, Basil M.;Lee, Seung Hyun;Baraka, Abakar S.;Joo, Hyunchel;Yajima, Shin;Elde, Stefan;Woo, Y. Joseph
  • 通讯作者:
    Woo, Y. Joseph
Outcomes after concomitant arch replacement at the time of aortic root surgery.
主动脉根部手术同时进行弓形置换后的结果。
  • DOI:
    10.1016/j.xjon.2022.12.014
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Krishnan,Aravind;Dalal,AlexR;Pedroza,AlbertJames;Nakamura,Ken;Yokoyama,Nobu;Tognozzi,Emily;Woo,YJoseph;Fischbein,Michael;MacArthur,JohnWard
  • 通讯作者:
    MacArthur,JohnWard
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Peter Fischbein其他文献

Michael Peter Fischbein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Peter Fischbein', 18)}}的其他基金

R38 Stanford Integrated Cardiovascular/Pulmonary Residency Research Training Program
R38 斯坦福综合心血管/肺部住院医师研究培训计划
  • 批准号:
    10358507
  • 财政年份:
    2020
  • 资助金额:
    $ 32.86万
  • 项目类别:
Marfan Aortic Embryologic Origin Influences miR-29b Regulators and Targets
马凡主动脉胚胎起源影响 miR-29b 调节因子和靶点
  • 批准号:
    9912106
  • 财政年份:
    2016
  • 资助金额:
    $ 32.86万
  • 项目类别:
Marfan Aortic Embryologic Origin Influences Aneurysm Formation
马凡主动脉胚胎起源影响动脉瘤的形成
  • 批准号:
    10551326
  • 财政年份:
    2016
  • 资助金额:
    $ 32.86万
  • 项目类别:
Marfan Aortic Embryologic Origin Influences Aneurysm Formation
马凡主动脉胚胎起源影响动脉瘤的形成
  • 批准号:
    10366102
  • 财政年份:
    2016
  • 资助金额:
    $ 32.86万
  • 项目类别:
Marfan Aortic Embryologic Origin Influences miR-29b Regulators and Targets
马凡主动脉胚胎起源影响 miR-29b 调节因子和靶点
  • 批准号:
    9251230
  • 财政年份:
    2016
  • 资助金额:
    $ 32.86万
  • 项目类别:
Marfan Aortic Embryologic Origin Influences miR-29b Regulators and Targets
马凡主动脉胚胎起源影响 miR-29b 调节因子和靶点
  • 批准号:
    9105863
  • 财政年份:
    2016
  • 资助金额:
    $ 32.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了